124 related articles for article (PubMed ID: 31188577)
1. Comprehensive Identification of Amadori Compound-Modified Phosphatidylethanolamines in Human Plasma.
He X; Chen GY; Zhang Q
Chem Res Toxicol; 2019 Jul; 32(7):1449-1457. PubMed ID: 31188577
[TBL] [Abstract][Full Text] [Related]
2. A UPLC-MRM-MS method for comprehensive profiling of Amadori compound-modified phosphatidylethanolamines in human plasma.
He X; Li Z; Zhang Q
Anal Bioanal Chem; 2021 Jan; 413(2):431-443. PubMed ID: 33111151
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Purification, and Mass Spectrometric Characterization of Stable Isotope-Labeled Amadori-Glycated Phospholipids.
He X; Zhang Q
ACS Omega; 2018 Nov; 3(11):15725-15733. PubMed ID: 30533579
[TBL] [Abstract][Full Text] [Related]
4. Tandem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma.
Miyazawa T; Oak JH; Nakagawa K
Ann N Y Acad Sci; 2005 Jun; 1043():280-3. PubMed ID: 16037249
[TBL] [Abstract][Full Text] [Related]
5. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.
Nakagawa K; Oak JH; Higuchi O; Tsuzuki T; Oikawa S; Otani H; Mune M; Cai H; Miyazawa T
J Lipid Res; 2005 Nov; 46(11):2514-24. PubMed ID: 16150834
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients.
Suzuki K; Nakagawa K; Miyazawa T
Clin Chem Lab Med; 2014 Jan; 52(1):47-52. PubMed ID: 23454716
[TBL] [Abstract][Full Text] [Related]
7. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.
Shoji N; Nakagawa K; Asai A; Fujita I; Hashiura A; Nakajima Y; Oikawa S; Miyazawa T
J Lipid Res; 2010 Aug; 51(8):2445-53. PubMed ID: 20386060
[TBL] [Abstract][Full Text] [Related]
9. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples.
Oak JH; Nakagawa K; Miyazawa T
J Lipid Res; 2002 Mar; 43(3):523-9. PubMed ID: 11893788
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of glycated phosphatidylethanolamines: evidence of oxidation in glycated polar head identified by LC-MS/MS.
Simões C; Simões V; Reis A; Domingues P; Domingues MR
Anal Bioanal Chem; 2010 Jul; 397(6):2417-27. PubMed ID: 20499053
[TBL] [Abstract][Full Text] [Related]
11. Development of quantitation method for glycated aminophospholipids at the molecular species level in powdered milk and powdered buttermilk.
Kodate A; Otoki Y; Shimizu N; Ito J; Kato S; Umetsu N; Miyazawa T; Nakagawa K
Sci Rep; 2018 Jun; 8(1):8729. PubMed ID: 29880856
[TBL] [Abstract][Full Text] [Related]
12. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes--influence of glycation products on lipid peroxidation.
Breitling-Utzmann CM; Unger A; Friedl DA; Lederer MO
Arch Biochem Biophys; 2001 Jul; 391(2):245-54. PubMed ID: 11437356
[TBL] [Abstract][Full Text] [Related]
13. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.
Sookwong P; Nakagawa K; Fujita I; Shoji N; Miyazawa T
Lipids; 2011 Oct; 46(10):943-52. PubMed ID: 21732214
[TBL] [Abstract][Full Text] [Related]
14. Photooxidation of glycated and non-glycated phosphatidylethanolamines monitored by mass spectrometry.
Melo T; Silva EM; Simões C; Domingues P; Domingues MR
J Mass Spectrom; 2013 Jan; 48(1):68-78. PubMed ID: 23303749
[TBL] [Abstract][Full Text] [Related]
15. Identification of deoxy-D-fructosyl phosphatidylethanolamine as a non-enzymic glycation product of phosphatidylethanolamine and its occurrence in human blood plasma and red blood cells.
Lertsiri S; Shiraishi M; Miyazawa T
Biosci Biotechnol Biochem; 1998 May; 62(5):893-901. PubMed ID: 9648220
[TBL] [Abstract][Full Text] [Related]
16. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells.
Oak JH; Nakagawa K; Oikawa S; Miyazawa T
FEBS Lett; 2003 Dec; 555(2):419-23. PubMed ID: 14644453
[TBL] [Abstract][Full Text] [Related]
17. A convenient method for preparation of high-purity, Amadori-glycated phosphatidylethanolamine and its prooxidant effect.
Miyazawa T; Oak JH; Nakagawa K
Ann N Y Acad Sci; 2005 Jun; 1043():276-9. PubMed ID: 16037248
[TBL] [Abstract][Full Text] [Related]
18. Modified phosphatidylethanolamines induce different levels of cytokine expression in monocytes and dendritic cells.
Simões C; Silva AC; Domingues P; Laranjeira P; Paiva A; Domingues MR
Chem Phys Lipids; 2013; 175-176():57-64. PubMed ID: 23942208
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic potency of Amadori-glycated phosphatidylethanolamine.
Nakagawa K; Oak JH; Miyazawa T
Ann N Y Acad Sci; 2005 Jun; 1043():413-6. PubMed ID: 16037263
[TBL] [Abstract][Full Text] [Related]
20. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor.
Higuchi O; Nakagawa K; Tsuzuki T; Suzuki T; Oikawa S; Miyazawa T
J Lipid Res; 2006 May; 47(5):964-74. PubMed ID: 16470027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
